Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BVAXF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2514 +34.77%
on 10/06/21
0.4900 -30.86%
on 09/23/21
-0.0943 (-21.77%)
since 09/21/21
3-Month
0.1500 +125.87%
on 08/31/21
0.5040 -32.78%
on 09/20/21
+0.1488 (+78.32%)
since 07/21/21
52-Week
0.0460 +636.52%
on 11/25/20
0.6200 -45.35%
on 02/16/21
+0.0249 (+7.93%)
since 10/21/20

Most Recent Stories

More News
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

/PRNewswire/ -- USA News Group - It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction,...

BVAXF : 0.3310 (+0.30%)
ABT : 125.01 (+1.38%)
BDX : 246.25 (-0.26%)
QDEL : 134.60 (+2.67%)
CVS : 86.07 (-0.55%)
BIOV.CN : 0.415 (+2.47%)
Are We Coming to the End of Using the PCR Covid-19 Test?

VANCOUVER – Biotech Today – It may have its beginning for the UK travel industry, but there ...

BVAXF : 0.3310 (+0.30%)
BDX : 246.25 (-0.26%)
QDEL : 134.60 (+2.67%)
CVS : 86.07 (-0.55%)
ABT : 125.01 (+1.38%)
BDX.CN : 0.550 (unch)
BIOV.CN : 0.415 (+2.47%)
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Recently, scientific reports have shown that a universal coronavirus vaccine that protects against...

BVAXF : 0.3310 (+0.30%)
MRNA : 339.26 (+1.88%)
SRNE : 6.60 (+1.54%)
DVAX : 18.25 (+0.11%)
INO : 7.06 (+0.28%)
BIOV.CN : 0.415 (+2.47%)
BioVaxys kündigt Posterpräsentation von BVX-0320 auf der virtuellen ISIRV-WHO-Konferenz an

/PRNewswire/ -- BioVaxys Technology Corp.(CSE: BIOV, FRA:5LB, OTCQB:BVAXF) („BioVaxys" oder „Unternehmen") gab heute bekannt, dass ein Poster mit den...

BVAXF : 0.3310 (+0.30%)
BioVaxys annonce la présentation de l'affiche BVX-0320 à la conférence virtuelle ISIRV-WHO

/PRNewswire/ -- BioVaxys Technology Corp. (CSE : BIOV, FRA:5LB, OTCQB:BVAXF) (« BioVaxys » ou « Société »), a annoncé aujourd'hui qu'une affiche mettant en...

BVAXF : 0.3310 (+0.30%)
BioVaxys beginnt Toxizitätsstudie im Vorfeld des IND-Antrags für CoviDTH

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) („BioVaxys" oder „Unternehmen") gab heute bekannt, dass es parallel zur...

BVAXF : 0.3310 (+0.30%)
NOTV : 33.18 (-0.06%)
BioVaxys anuncia la presentación del póster BVX-0320 en la conferencia virtual ISIRV-OMS

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" o "Compañía"), anunció hoy que un póster que destaca sus datos...

BVAXF : 0.3310 (+0.30%)
BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that a poster highlighting its...

BVAXF : 0.3310 (+0.30%)
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab

/PRNewswire/ -- USA News Group - As vaccine passport programs continue to roll out in new markets across the globe, especially in Europe and North America, it...

BVAXF : 0.3310 (+0.30%)
NVAX : 138.65 (+1.31%)
SNY : 49.04 (-0.02%)
GSK : 39.38 (-0.20%)
INO : 7.06 (+0.28%)
Alternative Covid-19 Vaccines on the Way, as Biotech Developers Seek to Improve Upon the Jab

VANCOUVER – Biotech Today – As vaccine passport programs continue to roll out in new markets ...

BVAXF : 0.3310 (+0.30%)
NVAX : 138.65 (+1.31%)
SNY : 49.04 (-0.02%)
GSK : 39.38 (-0.20%)
INO : 7.06 (+0.28%)
BIOV.CN : 0.415 (+2.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.4813
2nd Resistance Point 0.4307
1st Resistance Point 0.3803
Last Price 0.3310
1st Support Level 0.2793
2nd Support Level 0.2287
3rd Support Level 0.1783

See More

52-Week High 0.6200
Fibonacci 61.8% 0.4007
Fibonacci 50% 0.3330
Last Price 0.3310
Fibonacci 38.2% 0.2653
52-Week Low 0.0460

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar